Controlled clinical study with Fentiazac suspension in painful inflammatory diseases of children.
In a parallel double-blind trial with fifty paediatric patients, the anti-inflammatory, anti-exudative and antipyretic effects of Fentiazac suspension were compared with Benzidamine drops in the treatment of painful inflammatory conditions. Both drugs proved to be effective in relieving the signs and symptoms considered, though Fentiazac was shown to be more rapid and active. Body temperature was lowered by both drugs. Patients treated with Fentiazac suspension had a normal temperature after 3 days of treatment whereas in the Benzidamine-treated group the same result was reached only after 4 days (p less than 0.01). There was no subjective or objective evidence of local and/or systemic intolerance to either test drug.
D000085:Acetates / Q000627:therapeutic use*; D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001591:Benzydamine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D005334:Fever / Q000188:drug therapy*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D013535:Suspensions; D013844:Thiazoles
D000085:Acetates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013535:Suspensions; D013844:Thiazoles; C006124:fentiazac; D001591:Benzydamine